Vice President and Executive Director Xie Xin increased his holding of China Biotech Pharmaceutical (01177.HK) by 1 million shares at a price of approximately 7.37 Hong Kong dollars per share.

According to the wise financial APP, the latest information from the Hong Kong Stock Exchange shows that on August 20, the Vice President and Executive Director Xie Xin increased his stake in China Biotech (01177.HK) by 1 million shares at a price of 7.368 Hong Kong dollars per share, with a total amount of 7.368 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 360 million shares, and the latest shareholding ratio is 1.92%.